U.S. Markets close in 3 hrs 28 mins

Aethlon Medical, Inc. (AEMD)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.00-0.05 (-2.44%)
As of 12:27PM EDT. Market open.
People also watch
CTSOAMARBLFSAKERADXS

Aethlon Medical, Inc.

9635 Granite Ridge Drive
Suite 100
San Diego, CA 92123
United States
858-459-7800
http://www.aethlonmedical.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees5

Key Executives

NameTitlePayExercisedAge
Mr. James A. Joyce Ph.D.Founder, Chairman and Chief Exec. Officer645.42kN/A55
Mr. Rodney S. KenleyPres and Director318.75kN/A67
Mr. James B. FrakesChief Financial Officer351.43kN/A60
Mr. Sunil SawhneyHead of Clinical StudiesN/AN/AN/A
Dr. Kenneth R. Michael PharM.D., R.A.C.Regulatory and Clinical AdvisorN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in cancer, infectious diseases, and other life-threatening conditions in the United States. The company develops Aethlon Hemopurifier, a medical device, which targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Its Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. The company is also involved in developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. Aethlon Medical, Inc. was founded in 1991 and is based in San Diego, California.

Corporate Governance

Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.